MAP1LC3B and adrenal cortex carcinoma: Similarly, non-metastatic ACC showed a significantly higher percentage of LC3B positive cells than metastasized ACC (18.77 ± 3.52% <i>vs</i> 5.83 ± 1.70%, <i>p</i> = 0.004).